The use of a medical dictionary for regulatory activities terminology (MedDRA) in prescription-event monitoring in Japan (J-PEM)

被引:23
作者
Yokotsuka, M [1 ]
Aoyama, M [1 ]
Kubota, K [1 ]
机构
[1] Univ Tokyo, Fac Med, Dept Pharmacoepidemiol, Bunkyo Ku, Tokyo 1138655, Japan
关键词
adverse event; adverse drug reaction; terminology; postmarketing; prescription-event monitoring;
D O I
10.1016/S1386-5056(00)00062-9
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
The Medical Dictionary for Regulatory Activities Terminology (MedDRA) version 2.1 (V2.1) was released in March 1999 accompanied by the MedDRA/J V2.1J specifically for Japanese users. In prescription-event monitoring in Japan (J-PEM), we have employed the MedDRA/J for data entry, signal generation and event listing. In J-PEM, the lowest level terms (LLTs) in the MedDRA/J are used in data entry because the richness of LLTs is judged to be advantageous. A signal is generated normally at the preferred term (PT) level, but it has been found that various reporters describe the same event using descriptions that are potentially encoded by LLTs under different PTs. In addition, some PTs are considered too specific to generate the proper signal. In the system used in J-PEM, when an LLT is selected as a candidate to encode an event, another LLT under a different PT, if any, is displayed on the computer screen so that it may be coded instead of, or in addition to, the candidate LLT. The five-level structure of the MedDRA is used when listing events but some modification is required to generate a functional event list. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:139 / 153
页数:15
相关论文
共 20 条
[1]  
[Anonymous], INT J PHARM MED
[2]  
BROUWN EG, 1996, PHARM MED, V10, P111
[3]   The Medical Dictionary for Regulatory Activities (MedDRA) [J].
Brown, EG ;
Wood, L ;
Wood, S .
DRUG SAFETY, 1999, 20 (02) :109-117
[4]  
BROWN EG, 1998, INT J PHARM MED, V12, P23
[5]   Nicorandil and diabetes: a nested case-control study to examine a signal generated by prescription-event monitoring [J].
Dunn, N ;
Freemantle, S ;
Mann, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (02) :159-162
[6]   Cohort study on calcium channel blockers, other cardiovascular agents, and the prevalence of depression [J].
Dunn, NR ;
Freemantle, SN ;
Mann, RD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (02) :230-233
[7]  
FREEMANTLE SN, 1997, DRUG SAFETY, V6, pS1
[8]  
INMAN W, 1993, DRUG SAFETY, V6, P499
[9]  
INMAN W, 1993, DRUG SAFETY, V6, P259
[10]  
KUBOTA K, 1994, EUR J CLIN PHARMACOL, V46, P497